Diabetic patients are one of the populations with very high risk in terms of developing cardiovascular diseases, which are also the most common cause of their morbidity. Cardiovascular prevention in one of the pillars of diabetic treatment.
Serum lipoproteins are characteristically modified in their quantity and quality, so the treatment of this type of dyslipidemia has its own specifics.